Innoviva (INVA) Dividend Coverage Ratio Growth (3y) (2017 - 2022)
Powered by 
Analysis
Innoviva (INVA) Dividend Coverage Ratio Growth (3y) (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -41.07% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 2.30% |
| Jun 30, 2022 | -98.02% |
| Mar 31, 2022 | -91.69% |
| Sep 30, 2021 | -38.48% |
| Jun 30, 2021 | -59.72% |
| Mar 31, 2021 | -76.22% |
| Dec 31, 2020 | -63.25% |
| Jun 30, 2020 | -80.69% |
| Mar 31, 2020 | -74.56% |
| Sep 30, 2019 | -76.45% |
| Jun 30, 2019 | 374.55% |
| Mar 31, 2019 | 781.41% |
| Dec 31, 2018 | 55.21% |
| Sep 30, 2018 | 434.01% |
| Jun 30, 2018 | 534.05% |
| Mar 31, 2018 | 861.62% |
| Jun 30, 2017 | 1,465.74% |